Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-022242

Chief Medical Officer sold 407 shares at $25.00 ($10,175)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Farwell Wildon Chief Medical Officer 2024-02-28 Sale 10b5-1 −407 $25.00 $10,175 163,096 D: show line 1 in the form
Open-market sales · 407 sh · avg $25.00 · $10,175
Loading xslF345X05/ownership.xml…